Mayo Clinic Rochester, Rochester, MN, USA.
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720905950. doi: 10.1177/2150132720905950.
Restless legs syndrome (RLS) affects about 20% of all pregnant women. RLS symptoms are usually moderate to severe in intensity during pregnancy and can result in insomnia, depression, and other adverse outcomes. Although iron deficiency has been implicated as a potential etiological factor, other mechanisms can also play a role. Nonpharmacologic methods are the primary recommended form of treatment for RLS in pregnancy and lactation. Iron supplementation may be considered when the serum ferritin is low; however, several patients are unable to tolerate iron or have severe symptoms despite oral iron replacement. Here, we describe a case of severe RLS in pregnancy and illustrate the dilemmas in diagnosis and management. We review the literature on the prevalence, diagnosis, course, possible underlying pathophysiologic mechanisms and complications of RLS in pregnancy. We describe current best evidence on the efficacy, and safety of nonpharmacologic therapies, oral and intravenous iron supplementation, as well as other medication treatments for RLS in pregnancy and lactation. We highlight gaps in the literature and provide a practical guide for the clinical management of RLS in pregnancy and during breastfeeding.
不宁腿综合征(RLS)影响所有孕妇的 20%左右。RLS 症状在妊娠期间通常为中重度,可导致失眠、抑郁和其他不良后果。尽管缺铁被认为是潜在的病因因素,但其他机制也可能起作用。非药物治疗是非妊娠和哺乳期 RLS 的主要推荐治疗方法。当血清铁蛋白低时,可考虑补充铁;然而,一些患者无法耐受铁或尽管口服铁补充仍有严重症状。在这里,我们描述了一例妊娠重度 RLS 病例,并说明了诊断和管理中的困境。我们复习了 RLS 在妊娠中的患病率、诊断、病程、可能的潜在病理生理机制和并发症的文献。我们描述了非药物治疗、口服和静脉铁补充以及其他药物治疗 RLS 在妊娠和哺乳期的有效性和安全性的最新最佳证据。我们强调了文献中的空白,并为妊娠和哺乳期 RLS 的临床管理提供了实用指南。